Jeil Pharm (002620)

Currency in KRW
8,730
-20(-0.23%)
Closed·
002620 Scorecard
Full Analysis
Trading at a low Price / Book multiple
002620 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8,6608,790
52 wk Range
6,95011,070
Key Statistics
Bid/Ask
8,680.00 / 8,730.00
Prev. Close
8,750
Open
8,750
Day's Range
8,660-8,790
52 wk Range
6,950-11,070
Volume
1.4K
Average Volume (3m)
21.46K
1-Year Change
-2.34%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002620 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Jeil Pharm Company Profile

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. The company was founded in 1959 and is headquartered in Seoul, South Korea.

Employees
37

Compare 002620 to Peers and Sector

Metrics to compare
002620
Peers
Sector
Relationship
P/E Ratio
−2.7x9.1x−0.5x
PEG Ratio
0.030.010.00
Price/Book
0.4x0.9x2.6x
Price / LTM Sales
0.2x0.6x3.3x
Upside (Analyst Target)
-52.2%42.9%
Fair Value Upside
Unlock32.7%6.2%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -3,157.93%
Dividend Yield
0.57%
Industry Median 0.93%
Annualised payout
50.00
Paid annually
5-Years Growth
-6.51%
Growth Streak

Earnings

Latest Release
May 15, 2025
EPS / Forecast
149.64 / --
Revenue / Forecast
182.04B / --
EPS Revisions
Last 90 days

002620 Income Statement

FAQ

What Stock Exchange Does Jeil Pharm Trade On?

Jeil Pharm is listed and trades on the Seoul Stock Exchange stock exchange.

What Is the Stock Symbol for Jeil Pharm?

The stock symbol for Jeil Pharm is "002620."

What Is the Jeil Pharm Market Cap?

As of today, Jeil Pharm market cap is 134.32B.

What Is Jeil Pharm's Earnings Per Share (TTM)?

The Jeil Pharm EPS (TTM) is -3,157.93.

From a Technical Analysis Perspective, Is 002620 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Jeil Pharm Stock Split?

Jeil Pharm has split 4 times.

How Many Employees Does Jeil Pharm Have?

Jeil Pharm has 37 employees.

What is the current trading status of Jeil Pharm (002620)?

As of 12 Aug 2025, Jeil Pharm (002620) is trading at a price of 8,730.00, with a previous close of 8,750.00. The stock has fluctuated within a day range of 8,660.00 to 8,790.00, while its 52-week range spans from 6,950.00 to 11,070.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.